Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB06414_DB08870> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB06414_DB08870 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06414_DB08870 label "DDI between Etravirine and Brentuximab vedotin - Brentuximab, when used concomitantly with etravirine, may experience a decrease in serum concentrations. The levels of an active metabolite of brentuximab, monomethyl auristatin E, may decrease. It is recommended to monitor efficacy of brentuximab therapy. [drugbank_resource:DB06414_DB08870]" assertion.
- drugbank_resource:DB06414_DB08870 identifier "drugbank_resource:DB06414_DB08870" assertion.
- drugbank_resource:DB06414_DB08870 title "DDI between Etravirine and Brentuximab vedotin - Brentuximab, when used concomitantly with etravirine, may experience a decrease in serum concentrations. The levels of an active metabolite of brentuximab, monomethyl auristatin E, may decrease. It is recommended to monitor efficacy of brentuximab therapy." assertion.